Akido Secures $60 Million to Expand ScopeAI in Healthcare
Akido Labs has raised $60 million in Series B funding to expand the reach of its AI healthcare system, ScopeAI, announced in a press release. The funding round was led by Oak HC/FT, with participation from Greco, SNR, and existing investors including Y Combinator and Google DeepMind's Jeff Dean.
ScopeAI is designed to integrate AI into healthcare provider visits, allowing providers to manage more patients without sacrificing care quality. The system uses AI to assist medical assistants during patient visits, generating comprehensive clinical reports and preliminary diagnoses. This approach aims to address the physician shortage by increasing clinical capacity and improving healthcare access.
With the new funding, Akido plans to accelerate the deployment of ScopeAI across its network of 240 providers in 26 specialties. The company also aims to enter new markets, such as a healthcare program in New York City targeting chronic diseases for rideshare drivers. Founded in 2015, Akido continues to leverage AI to enhance healthcare delivery and access.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Heidi Raises $340 Million for Health Care AI Expansion
Parakeet Health raises $10 million for AI patient access platform
Ando Raises $20 Million for AI Agent Messaging Platform
AbbVie Partners With Valkai on AI Tools for Clinical Development
Sopris Capital Acquires Blackford Analysis from Bayer
Daily AI Brief: the AI news that matters, in your inbox.